UChicago Medicine

https://www.uchicagomedicine.org/

 

19th Annual International Ultmann Chicago Lymphoma Symposium
15:36

19th Annual International Ultmann Chicago Lymphoma Symposium

Treatment of 1st Relapsed Classical Hodgkin Lymphoma

FEATURING Vaishalee Kenkre
  • 156 views
  • July 11, 2022
12:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Targeted Agents in Follicular Lymphoma: Small Molecules

FEATURING Tycel Phillips
  • 62 views
  • July 11, 2022
19:06

19th Annual International Ultmann Chicago Lymphoma Symposium

Primary CNS Lymphoma: Focus on Consolidation

FEATURING Tracy Batchelor
  • 59 views
  • July 11, 2022
  • 1
20:01

19th Annual International Ultmann Chicago Lymphoma Symposium

CAR T-Cell Constructs in Lymphoma: Current and Future Options

FEATURING Tanya Siddiqi
  • 30 views
  • July 11, 2022
54:37

19th Annual International Ultmann Chicago Lymphoma Symposium

Toxicities Associated With Chronic Therapies for Lymphoma: Case Studies

FEATURING Nicole Soriano, Katherine Thorp
  • 72 views
  • July 11, 2022
19:38

19th Annual International Ultmann Chicago Lymphoma Symposium

CAR T-Cell Therapy and Emerging Bispecifics for the Treatment of Follicular Lymphoma

FEATURING Saira Ahmed
  • 26 views
  • July 11, 2022
20:03

19th Annual International Ultmann Chicago Lymphoma Symposium

Biology of Follicular Lymphoma

FEATURING Robert Kridel
  • 65 views
  • July 11, 2022
25:29

19th Annual International Ultmann Chicago Lymphoma Symposium

Mantle Cell Lymphoma: Case-Based Approach to Management

FEATURING Reem Karmali
  • 568 views
  • July 11, 2022
  • 5
20:13

19th Annual International Ultmann Chicago Lymphoma Symposium

Bispecific Antibodies in Lymphomas

FEATURING Rajat Bannerji
  • 82 views
  • July 11, 2022
20:16

19th Annual International Ultmann Chicago Lymphoma Symposium

How to Sequence Non-CAR T-Cell Therapy for Relapsed DLBCL

FEATURING Daniel Landsburg
  • 30 views
  • July 11, 2022
19:22

19th Annual International Ultmann Chicago Lymphoma Symposium

Prevention of CNS Progression in DLBCL

FEATURING Craig Portell
  • 26 views
  • July 11, 2022
19:28

19th Annual International Ultmann Chicago Lymphoma Symposium

Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Treatment

FEATURING Christian Steidl
  • 110 views
  • July 11, 2022
  • 1
19:37

19th Annual International Ultmann Chicago Lymphoma Symposium

Hodgkin Lymphoma Updates: Relapse After Auto-HCT, Brentuximab Vedotin, and Checkpoint Inhibitors - The Next Frontier

FEATURING Anna Sureda
  • 43 views
  • July 11, 2022
42:23

19th Annual International Ultmann Chicago Lymphoma Symposium

COVID-19 in Patients With Lymphoma: Treatment Approaches, Vaccination, and Prophylactic Strategies

FEATURING Natasha Pettit
  • 161 views
  • July 11, 2022
24:15

19th Annual International Ultmann Chicago Lymphoma Symposium

Treatment of Relapsed CNS Lymphomas

FEATURING Andres Ferreri
  • 43 views
  • July 11, 2022
24:14

19th Annual International Ultmann Chicago Lymphoma Symposium

Prognostication and Treatment of Burkitt Lymphoma in the Modern Era

FEATURING Adam Olszewski
  • 94 views
  • July 11, 2022
48:49

19th Annual International Ultmann Chicago Lymphoma Symposium

Recent Advances in the Frontline Treatment of DLBCL: Is There a New Standard of Care?

FEATURING Laurie H. Sehn
  • 492 views
  • July 8, 2022
38:14

19th Annual International Ultmann Chicago Lymphoma Symposium

Cellular Therapy in Lymphoma: Where Are We Now?

FEATURING Peter Riedell
  • 145 views
  • July 8, 2022
17:54

19th Annual International Ultmann Chicago Lymphoma Symposium

Debate: Auto-HCT Remains the Preferred Standard of Care for 1L Therapy of MCL

FEATURING Timothy Fenske
  • 299 views
  • July 8, 2022
  • 2
14:38

19th Annual International Ultmann Chicago Lymphoma Symposium

Debate: We Should Stop Doing Autotransplants for Patients With MCL in 1st Remission

FEATURING Patrick Stiff
  • 17 views
  • July 8, 2022
19:52

19th Annual International Ultmann Chicago Lymphoma Symposium

CLL: Present and Future

FEATURING Nicole Lamanna
  • 282 views
  • July 8, 2022
  • 1
19:38

19th Annual International Ultmann Chicago Lymphoma Symposium

T-Cell Lymphomas: Impact of Classification on Treatment

FEATURING Neha Mehta-Shah
  • 482 views
  • July 8, 2022
  • 3
20:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Post-Acute Outcomes After HL: An Epidemiologic Perspective

FEATURING Lindsay Morton
  • 65 views
  • July 8, 2022
  • 1
28:22

19th Annual International Ultmann Chicago Lymphoma Symposium

Follicular Lymphoma Management in the COVID-19 Era

FEATURING Leo Gordon
  • 32 views
  • July 8, 2022
41:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis, and Treatment

FEATURING Kenneth Cohen
  • 152 views
  • July 8, 2022
17:53

19th Annual International Ultmann Chicago Lymphoma Symposium

Sequencing of Therapies in R/R MCL

FEATURING Kami Maddocks
  • 172 views
  • July 8, 2022
22:11

19th Annual International Ultmann Chicago Lymphoma Symposium

High-Grade B-Cell Lymphomas, Not Otherwise Specified: How To Differentiate and What To Do?

FEATURING David Scott
  • 40 views
  • July 8, 2022
  • 1